FDA approves remdesivir as treatment for COVID-19 patients in hospital

The Food and Drug Administration (FDA) on Thursday approved the antiviral drug remdesivir as a treatment for patients with COVID-19 who require hospitalization.

Given through an IV, remdesivir works to stop replication of SARS-CoV-2, the virus that causes COVID-19, according to the drug's manufacturer, California-based Gilead Sciences, Inc. Previously authorized by the FDA for emergency use to treat COVID-19, the drug is now the first and only approved COVID-19 treatment in the United States, Gilead said in a release.

“Since the beginning of the COVID-19 pandemic, Gilead has worked relentlessly...